/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Dr. Reddy's Laboratories Ltd. Share Price Today: Live Updates & Key Insights

Dr. Reddy's Laboratories Ltd. share price today is $14.35, up -1.31%. The stock opened at $14.43 against the previous close of $14.54, with an intraday high of $14.5 and low of $14.33.

Dr. Reddy's Laboratories Ltd. Share Price Chart

style
pb-0

Dr. Reddy's Laboratories Ltd.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Dr. Reddy's Laboratories Ltd. Share Price Performance

$14.35 -0.0131(-1.31%) RDY at 13 Mar 2026 03:00 PM Drug Manufacturers - Specialty & Generic
Lowest Today 14.33
Highest Today 14.5
Today’s Open 14.43
Prev. Close 14.54
52 Week High 16.07
52 Week Low 12.18
Day’s Range: Low 14.33 High 14.5
52-Week Range: Low 12.18 High 16.07
1 day return -
1 Week return -0.17
1 month return +1.59
3 month return +1.73
6 month return -1.91
1 year return +13.42
3 year return -73.25
5 year return -76.16
10 year return -

Dr. Reddy's Laboratories Ltd. Institutional Holdings

Robeco Institutional Asset Management BV 1.58

JPMorgan Chase & Co 1.45

BlackRock Inc 1.34

Royal Bank of Canada 1.22

Renaissance Technologies Corp 0.99

Aikya Investment Management Ltd 0.88

Morgan Stanley - Brokerage Accounts 0.76

RBC Emerging Markets Equity 0.67

RBC Emerging Markets Equity Fund F 0.67

Dimensional Fund Advisors, Inc. 0.64

Vanguard Group Inc 0.60

State Street Corp 0.50

BNP Paribas Arbitrage, SA 0.50

Robeco QI EM Active Equities I € 0.29

Robeco QI Emerging Cnsrv Eqs I € 0.26

Acadian Asset Management LLC 0.24

Vanguard Emerging Mkts Stock Idx Inv 0.23

Fisher Asset Management, LLC 0.20

Vanguard Global Minimum Volatility Admr 0.20

Avantis Emerging Markets Equity ETF 0.19

State Street® SPDR® Portfolio EM ETF 0.18

American Century Companies Inc 0.16

Bessemer Group Inc 0.16

DFA Emerging Markets Core Equity 2 I 0.16

Creative Planning Inc 0.15

UBS Group AG 0.15

Jane Street Group LLC 0.14

Northern Trust Corp 0.13

JPM Emerging Mkts Opps A (acc) USD 0.11

JPM GEM Opportunities-Composite 0.11

Vanguard Total Intl Stock Index Inv 0.11

Lazard Asset Management LLC 0.09

Dimensional EM LrgCap Core Eq ZUSDInsAcc 0.07

DFA Emerging Markets I 0.06

SEI Emerging Markets Equity F (SIT) 0.06

RBC Emerging Markets ex China Equity 0.06

RBC Emerging Markets exChina Equity Fd O 0.06

PrivilEdge Robeco EM Bt Enh USD X1 MA 0.06

RAM (Lux) Sys Emg Mkts Equities B USD 0.06

Robeco QI Customized EM Enh Idx Eqs 0.05

Dr. Reddy's Laboratories Ltd. Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 1

Dr. Reddy's Laboratories Ltd. Fundamentals

Market Cap 12105.73 M

PB Ratio 3.0468

PE Ratio 20.1944

Enterprise Value 11837.25 M

Total Assets 492989.00 M

Volume 2504613

Dr. Reddy's Laboratories Ltd. Company Financials

Annual Revenue FY25:325535000000 325535.0M, FY24:279164000000 279164.0M, FY23:245879000000 245879.0M, FY22:214391000000 214391.0M, FY21:189722000000 189722.0M

Annual Profit FY25:190428000000 190428.0M, FY24:163607000000 163607.0M, FY23:202972000000 202972.0M, FY22:113840000000 113840.0M, FY21:103077000000 103077.0M

Annual Net worth FY25:56544000000 56544.0M, FY24:55684000000 55684.0M, FY23:45073000000 45073.0M, FY22:23568000000 23568.0M, FY21:19149000000 19149.0M

Quarterly Revenue Q4/2025:87268000000 87268.0M, Q3/2025:88051000000 88051.0M, Q2/2025:85452000000 85452.0M, Q1/2025:85060000000 85060.0M, Q4/2024:83586000000 83586.0M

Quarterly Profit Q4/2025:46806000000 46806.0M, Q3/2025:48140000000 48140.0M, Q2/2025:48627000000 48627.0M, Q1/2025:47263000000 47263.0M, Q4/2024:49052000000 49052.0M

Quarterly Net worth Q4/2025:12098000000 12098.0M, Q3/2025:14372000000 14372.0M, Q2/2025:14178000000 14178.0M, Q1/2025:15938000000 15938.0M, Q4/2024:14133000000 14133.0M

About Dr. Reddy's Laboratories Ltd. & investment objective

Company Information Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Organisation Drug Manufacturers - Specialty & Generic

Employees 27811

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Erez Israeli M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow